Efficacy and Safety of Trastuzumab Combined with Pertuzumab for Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer: A Meta-Analysis Study of Randomized Control Trials

Figure 7

Sensitivity analysis of systemic adverse reactions. (a) Sensitivity analysis of neutropenia. (b) Sensitivity analysis of fatigue. (c) Sensitivity analysis of rash. (d) Sensitivity analysis of myalgia. (e) Sensitivity analysis of all cardiac disorders.

(a)

(b)

(c)

(d)

(e)